相关实验视频

Updated: Jul 19, 2025

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Published on: April 3, 2009

在MCF-7乳腺癌细胞系中引发的氨3-糖化物诱导的亡

Seyed Abbas Mirmalek¹, Sholeh Faraji², Sanaz Ranjbaran²

¹Department of Surgery, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Archives of medical science : AMS

|August 10, 2023

概括

氨三糖化物 (C3G) 对乳腺癌细胞表现出剂量依赖的细胞毒性和亡性作用. 这种天然化合物显示出作为乳腺癌治疗的潜在新疗法的前景.

科学领域:

生物化学生物化学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

乳腺癌仍然是女性癌症相关死亡的主要原因.
耐药性需要探索新的治疗药物和抗癌药物.
丁3-糖化物 (C3G) 已显示出潜在的细胞毒性作用.

研究的目的:

研究C3G对MCF-7乳腺癌细胞系的抗癌作用.
评估C3G对细胞活力和细胞亡的影响.
分析参与细胞死亡途径的关键基因表达的调制.

主要方法:

在24小时和48小时内,MCF-7细胞接受了C3G的不同度的治疗.
用MTT测定来评估细胞活力.
通过Annexin V/propidium iodide染色和流动细胞计量来量化亡.
通过PCR分析了p53,Bax,Caspase3,CYP1,CYP2和Bcl2的基因表达.
西方血栓检测证实了CYP1蛋白水平.

主要成果:

C3G在MCF-7细胞上表现出剂量依赖的细胞毒性作用.
超过51.5%的细胞在C3G暴露后24小时内发生了细胞亡.
通过C3G治疗,可以提高p53,Bax,Caspase3,CYP1和CYP2的表达.
在C3G治疗下调了Bcl2.2的表达.
西方涂抹证实CYP1蛋白水平增加了2倍.

结论:

C3G对乳腺癌细胞具有显著的亡和细胞毒性.
这些发现表明C3G作为乳腺癌治疗剂的潜力.
对C3G作为癌症治疗的进一步研究是有必要的.

关键词:

它们是反扩散的.乳腺癌乳腺癌乳腺癌氨 3-糖化化物.草本草药是一种草本草药.

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

相关概念视频

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...